The issues of fighting urological cancer, new strategies and tactics of treatment were discussed at the International Oncology Congress held at Ivane Javakhishvili Tbilisi State University (TSU) on October 26. Leadings field experts from the United States, Germany, Sweden, France, Italy, Belgium, Great Britain, Russia, Ukraine, Armenia, Azerbaijan and Georgia participated in the congress. Vice Rector of TSU, Alexander Tsiskaridze, professors and students also attended the event.
Struggle against urological cancer is an important challenge in the today’s global medicine. There are absolutely new approaches and recommendations to defeat these pathologies. Just sharing these novelties as well as participation of Georgian doctors in the process of developing modern global medicine was the key goal of the conference. Vice Rector Alexander Tsiskaridze said before the conference that many innovative directions and ideas would be discussed at the meeting. “We expect very interesting discussions. It is very important for our residents and students. Transfer of knowledge is one of the main goals of similar conferences. In addition, participation of field experts means that a lot of innovative ideas and directions will be addressed that will promote the development of urology and particularly oncologic urology,” Alexander Tsiskaridze said.
Famous field experts summarized existing scientific innovations that will ensure scientific-practical and clinical progress, increase of knowledge and experience, introduction of progressive ideas.
Prof. Christopher Evans, President of the U.S. Society of Urologic Oncology, Chair of the Department of Urologic Surgery at the University of California, said that the participants would share knowledge, experience and research, adding that the conference “is very important” for medical doctors in terms of exchanging information on medical novelties and new methods of treatment.
President of Georgian Association of Oncological Urology, TSU Professor Guram Karazanashvili said that among other issues, the significance of stem cells in treatment of prostate cancer was discussed at the congress. “I hope that the congress will have a positive influence not only on Georgian medicine, but generally on the development of oncologic urology worldwide. This is a brilliant opportunity for Georgian doctors to familiarize themselves with modern achievements of oncology and urology. All aspects, novelties in surgery, radiation therapy, chemotherapy, immunotherapy, hormone therapy, anatomic pathology and generally in science will be discussed,” Guram Karazanashvili said.
“Urologic oncology is one of the problems in modern medicine and today we have an opportunity to listen to leading field experts as well as to discuss current issues. Holding the congress in Georgia is important not only from educational point of view, but also in terms of improving our health system and introducing modern medical technologies,” Prof. Zaal Kokaia of Lund University said.
Urologists, oncologists, radiologists and anatomic pathologists participated in the multidisciplinary congress, which ended on October 27. The congress sponsors were MMT Hospital, TSU and Shota Rustaveli National Science Foundation.
